Jaguar Health (JAGX) Invested Capital (2014 - 2017)
Jaguar Health's (JAGX) quarterly Invested Capital came in at $1.6 million in Q4 2017, down 16.17% year-on-year from $1.9 million in Q4 2016, and down 10.66% on a QoQ basis from $1.8 million in Q3 2017.
Jaguar Health (JAGX) Invested Capital (2014 - 2017) Analysis & Trends
Jaguar Health (JAGX) has 4 years of Invested Capital data on file, last reported at $1.6 million in Q4 2017.
- On a quarterly basis, Invested Capital fell 16.17% year-over-year to $1.6 million in Q4 2017; TTM through Sep 2018 was $1.6 million, a 79.33% decrease from a year earlier, with the FY2017 full-year figure at $1.6 million, down 16.17% from the prior year.
- Invested Capital for Q4 2017 stood at $1.6 million, down from $1.8 million in the prior quarter.
- Over the last five years, Invested Capital for JAGX reached as high as $2.1 million in Q1 2016 and fell as low as $16581.0 in Q4 2014.
- Historically, Invested Capital has averaged $1.5 million across 4 years, with a median of $1.8 million in 2015.
- Across the five-year window, Invested Capital jumped 10200.34% in 2015 and dropped 16.17% in 2017, its largest moves.
- Year by year, Invested Capital stood at $16581.0 in 2014, then soared by 10200.34% to $1.7 million in 2015, then advanced by 12.4% to $1.9 million in 2016, then dropped by 16.17% to $1.6 million in 2017.
- Per Business Quant data, the three most recent Invested Capital figures were $1.6 million in Q4 2017, $1.8 million in Q3 2017, and $2.1 million in Q2 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - | 108.47 Mn |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | 116.14 Mn |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn | - |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn | - |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn | - |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - | - |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 1.61 Mn |
| Sep 30, 2017 | 1.80 Mn |
| Jun 30, 2017 | 2.07 Mn |
| Mar 31, 2017 | 1.99 Mn |
| Dec 31, 2016 | 1.92 Mn |
| Sep 30, 2016 | 1.85 Mn |
| Jun 30, 2016 | 1.47 Mn |
| Mar 31, 2016 | 2.12 Mn |
| Dec 31, 2015 | 1.71 Mn |
| Sep 30, 2015 | 1.45 Mn |
| Mar 31, 2015 | 21,244.00 |
| Dec 31, 2014 | 16,581.00 |